Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant
US 800-774-4410
or +1-240-747-3094
Search Assistance >

Home  > Healthcare  >  Pharmaceutical  >  Drug Discovery

Immune/Inflammatory Disease: Early-Stage R&D Technologies and Dealmaking

Published Date: May 2009
Published By: Decision Resources
Page Count: 24
Order Code: R55-645
 
Questions About This Report
E-mail a Colleague
Printable Page
Fax Your Order
DescriptionTable of ContentsSimilar
Products

Executive Summary
Strategic Considerations
Stakeholder Implications
Introduction
What Market Awaits Innovative Therapies?
Novel Approaches to Inflammation/Autoimmune Disease Treatment
Novel Targets
MAP Kinases
Jak
Toll-Like Receptors
Novel Interleukins
Nuclear Factor-Kappa B
Phosphodiesterase 4
Novel Technologies
RNA-Based Therapeutics
Stem-Cell Therapy
Company Profiles
Archemix
Array BioPharma
Cellzome
Dynavax
Regulus Therapeutics
Outlook
Tables
1. Descriptions of Inflammatory and Autoimmune Diseases
2. Top-Selling Autoimmune and Anti-Inflammatory Treatments, 2008
3. Common Immune Treatments and their Targets
4. MAP Kinase Agents in Clinical Development for Autoimmune and Inflammatory Diseases
5. Jak Kinase Agents in Development for Autoimmune and Inflammatory Diseases
6. Toll-Like Receptor Agents in Development for Autoimmune and Inflammatory Diseases
7. IL-12, IL-17, and IL-23 Agents in Development for Autoimmune and Inflammatory Diseases
8. NF-ęB Agents in Development for Autoimmune and Inflammatory Diseases
9. PDE4 Agents in Development for Autoimmune and Inflammatory Diseases
10. Select Deals in Autoimmune and Inflammatory Disease Drug Development
11. Select Academic Collaborations in Autoimmune and Inflammatory Disease Drug Development
Figures
1. Worldwide Sales of Agents to Treat Inflammatory and Autoimmune Diseases, 2003-2008
2. Market Share of the Autoimmune and Inflammatory Disease Market by Company, 2008
Similar Products
• Prostate Cancer Drug Discoveries: What the Future Holds
Published Nov 2009 by Espicom Healthcare Intelligence

• Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO)
Published Nov 2009 by La Merie S.L.

• Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)
Published Nov 2009 by La Merie S.L.

• Competitor Analysis: FGF-R Agonists and Antagonists
Published Nov 2009 by La Merie S.L.

• BI for Drug Development: Oracle Introduces Clinical Development Analytics
Published Nov 2009 by IDC

• Canada's Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis
Published Nov 2009 by Aruvian's R'search

• Competitor Analysis: TGF-R Agonists and Antagonists
Published Nov 2009 by La Merie S.L.

• Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Published Oct 2009 by BioSeeker Group AB

• CDK Inhibitors Patent Landscape 2009
Published Oct 2009 by France Innovation Scientifique et Transfer

• Antidiabetics in Australia Market Forecast
Published Oct 2009 by Datamonitor



 

Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
Copyright Š 1999-2008, All Rights Reserved, MindBranch.com
Trust-e Logo
Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: support@mindbranch.com